HomepageEarnings Events Newsdesk 3 days ago LabCorp (LH) SureNano Science Initiates FDA Stage GLP Toxicology and Pharmacology Studies for GLP GEP-44 and Enters Discussions to Acquire Ibogaine Formulation IP Portfolio LabCorp (NYSE: LH) FY 2026 Other Release The Boston Beer Company, Inc (SAM) Q1 2026 Earnings Call » « Alpha Metallurgical Resources Inc (AMR) Releases Preliminary Results for First Quarter 2026 Newsdesk:
